Hilltop vs Texas Capital Bancshares
HTH and TXCP side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HTH and TXCP compare
Texas Capital Bancshares is the larger company, worth 2.0 times as much as Hilltop ($4.2B against $2.1B).
On earnings, Texas Capital Bancshares is cheaper: it trades at 12.8× trailing earnings, against 15.2× for Hilltop.
Texas Capital Bancshares grew revenue faster over the last twelve months (10.9% versus 0.21% for Hilltop).
Texas Capital Bancshares keeps more of each dollar of sales as profit, with a net margin of 27.0% compared with 11.2% at Hilltop.
Hilltop pays a dividend yielding 1.7%; Texas Capital Bancshares does not pay one.
Hilltop scores higher on the StockData Score (12 against 11 for Texas Capital Bancshares), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HTH | TXCP |
|---|---|---|
| Size and price | ||
| Market cap | $2.1B | $4.2B |
| Share price | $36.48 | $99.82 |
| Change, 1 year | 8.3% | 15.1% |
| Change, 5 years | 0.16% | 71.7% |
| Beta (5Y) | 0.69 | 0.80 |
| Employees | 3,500 | 1,785 |
| StockData Score | ||
| Total score | 12 (better) | 11 |
| Valuation score | 4 | 4 |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 3 (better) |
| Health score | 3 | 4 (better) |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | 15.2× | 12.8× (better) |
| P/S | 1.6× (better) | 3.2× |
| P/B | 1.0× (better) | 1.2× |
| P/FCF | 18.9× | 8.2× (better) |
| PEG | 0.84 (better) | 4.02 |
| FCF yield | 5.3% | 12.2% (better) |
| Fair value | $37.31 | $100.53 |
| Margin of safety | 2.2% (better) | 0.70% |
| Growth | ||
| Revenue growth (TTM) | 0.21% | 10.9% (better) |
| Revenue growth, 5Y average | −9.5% | 3.6% (better) |
| Net income growth (TTM) | −11.7% | 20.8% (better) |
| EPS growth (TTM) | −4.4% | 27.5% (better) |
| EPS growth, 5Y average | −12.0% | 43.4% (better) |
| Profitability | ||
| Net margin | 11.2% | 27.0% (better) |
| FCF margin | 8.8% | 38.6% (better) |
| Return on equity | 6.6% | 10.2% (better) |
| Financial health | ||
| Debt / equity | 0.39 | – |
| Altman Z-score | 0.28 (better) | 0.26 |
| Piotroski F-score | 5 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.7% | – |
| Payout ratio | 33.4% | – |
| Years of dividend growth | 9 | – |
| Dividend growth, 5Y average | 14.9% | – |
| Buyback yield | 8.5% (better) | 7.8% |
| Shareholder yield | 10.2% (better) | 7.8% |
| Ownership | ||
| Held by institutions | 56.3% | 110% |
| Held by insiders | 61.0% | 3.5% |
| Insider net buying, 12 months | −$15.3M | −$6.2M (better) |
| Short interest, % of float | 9.6% | – |
Go deeper
- HTH stock overview
- HTH income statement
- HTH valuation and score
- TXCP stock overview
- TXCP income statement
- TXCP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.